-
-
-
-
-
-
-
Athenex Provides Second Quarter 2022 Financial Results and Business Update
-
-
-
-
-
-
-
Athenex and the Center for Cell and Gene Therapy Announce Allowance of Our First U.S. Patent Claims Around CAR-NKT Cell Therapy
-
-
-
-
-
-
-
Pre-Open Movers 05/05: (CHMA) (ATNX) (IBIO) Higher; (COCP) (ESPR) (MCFE) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/26: (DNKN) (GMBL) (CYCC) Higher; (SAP) (HAS) (TPTX) Lower (more...)
-
-
-
-
-
-
-
SunGen Pharma Announces to Partner with Athenex Pharmaceutical to Launch Bivalirudin through PIV Challenges in US
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

